论文部分内容阅读
目的:通过对反复喘息的患儿采用辅舒酮(FP)联合万托林配合储雾罐吸入治疗,观察该方法在急性期控制症状和病后一年内喘息发生的情况。方法:治疗组在采取综合治疗基础上,应用FP及万托林配合储雾罐吸入治疗;在急性喘息好转后继续吸入辅舒酮12周,当出现咳嗽、流鼻涕等感冒症状时,再加万托林吸入,每天两次,感冒症状消失即停止吸入;对照组仅予常规综合治疗。结果两组患儿急性期在喘憋、肺部哮鸣音、咳嗽消失方面差异有统计学意义(t=6.237.78,5.79,P<0.01),且病后一年内喘息发生次数与喘息持续的时间,治疗组明显优于对照组(P<0.05)。结论:吸入辅舒酮及万托林对婴幼儿反复喘息的临床疗效确切,缓解喘息症状迅速,且短期吸入,可降低喘息再发的次数,可作为预防反复喘息的干预措施,安全性高,值得推广。
OBJECTIVE: To observe the effect of this method on symptom control and wheezing within one year after acute asthma in children with recurrent wheezing and inhalation of fufang ketone (FP) combined with vaterolin. Methods: On the basis of comprehensive treatment, the treatment group was treated with FP and vestamol inhalation therapy with aerosol canister. After acute asthma improvement, fuxi ketone was inhaled for 12 weeks. When symptoms of cough, runny nose and other cold symptoms appeared, Vetamine inhaled twice daily, the symptoms disappear to stop the cold inhalation; the control group only conventional treatment. Results The acute stage of two groups had statistically significant difference in wheezing, wheezing of lung and disappearance of cough (t = 6.237.78, 5.79, P <0.01), and the number of wheezing and wheezing in one year after illness Of the time, the treatment group was significantly better than the control group (P <0.05). CONCLUSIONS: Inhaled fevofluazone and wantropin have definite curative effect on recurrent wheezing in infants and young children. Relieving wheezing symptoms quickly and short-term inhalation can reduce the number of recurrent wheezing, which can be used as an intervention to prevent recurrent wheezing. It is safe, Worth promoting.